ArticleJournal of Cancer2021

Bioactive Hexapeptide Reduced the Resistance of Ovarian Cancer Cells to DDP by Affecting HSF1/HSP70 Signaling Pathway.

Ruowen Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.